Chemoinformaics analysis of 2,3-DIHYDRO-1-BENZOFURAN
| Molecular Weight | 120.151 | nRot | 0 |
| Heavy Atom Molecular Weight | 112.087 | nRig | 11 |
| Exact Molecular Weight | 120.058 | nRing | 2 |
| Solubility: LogS | -3.322 | nHRing | 1 |
| Solubility: LogP | 2.076 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 17 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 19.4963 |
| nHD | 0 | BPOL | 9.76166 |
| QED | 0.714 |
| Synth | 2.212 |
| Natural Product Likeliness | 1.014 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.143 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.539 |
| MDCK | 0.000025 |
| BBB | 0.396 |
| PPB | 0.874367 |
| VDSS | 0.984 |
| FU | 0.0671421 |
| CYP1A2-inh | 0.986 |
| CYP1A2-sub | 0.94 |
| CYP2c19-inh | 0.928 |
| CYP2c19-sub | 0.679 |
| CYP2c9-inh | 0.569 |
| CYP2c9-sub | 0.889 |
| CYP2d6-inh | 0.838 |
| CYP2d6-sub | 0.9 |
| CYP3a4-inh | 0.742 |
| CYP3a4-sub | 0.301 |
| CL | 10.065 |
| T12 | 0.49 |
| hERG | 0.034 |
| Ames | 0.48 |
| ROA | 0.767 |
| SkinSen | 0.794 |
| Carcinogencity | 0.907 |
| EI | 0.971 |
| Respiratory | 0.828 |
| NR-Aromatase | 0.081 |
| Antiviral | No |
| Prediction | 0.891946 |